top of page

Funding

We have listed below some of the key funding calls (mainly grants) that are applicable to companies in UK healthcare. For more information, please contact us.

Upcoming Funding Calls
Public Health Intervention Development

Funder: MRC

Opens: 25 July 2024

Closes: 12 September 2024 

Sector: Healthcare

Apply for funding for the early-stage development of an intervention that seeks to address a UK or global public health challenge. This might include qualitative and quantitative primary research and the development of theory and logic models. However, emphasis should be placed on developing the intervention.
 

You must be a researcher employed by an eligible research organisation.

MRC will fund up to £150,000, for a maximum of 18 months.
 

Funds requested by UK research organisations will be funded at 80% of the full economic cost, in which case the full economic cost of your project can be up to £187,500. Overseas costs will be funded at 100% of the full economic cost.
More information will be updated here.

Mental Health Award: Accelerating scalable digital mental health interventions

Funder: Wellcome

Open: 29 July 2024

Closes: 2 December 2024

Sector: Healthcare

This call will fund research to evaluate and further develop scalable digital interventions to advance early intervention in depression, anxiety and psychosis. Teams must include the research expertise required to drive the proposed research, an organisation which can take the intervention to scale (whether a company or not-for-profit) and lived experience experts.

£3 to £7 million per project, lasting up to 5 years.

There will be a series of thought-provoking events and discussions on digital mental health. The first event is Partnering for Progress: Building Industry-Academic Partnerships in Digital Mental Health on Thursday 18 July 2024, 17:00 to 19:30 BST. 

There will then be matchmaking events for companies and researchers during September 2024 and a funding webinar on 10 September 2024.
More information
here.

Competition 26 - Urgent & Emergency Care

Funder: SBRI

Opens: 31 July 2024

Closes: 1pm 18 September 2024

Sector: Healthcare

This competition aims to identify innovations at an advanced stage of development that address three priority areas:

  • Health and Care outside of Hospitals: Accessing the Right Care and Reducing Demand

  • Reducing Length of Stay and Improving Discharge

  • Supporting Workforce.

The aim of the competition is to facilitate the collection of evidence in real-world settings and build on the value proposition required by commissioners and regulators to accelerate the uptake of the innovation into relevant health or social care settings.

Maximum grant funding is £500,000 excluding VAT.

More information here.

Register for the launch webinar, Tues 23 July, 1-3pm. Sign up on Eventbrite

Current Funding Calls
Mental Health Award: applying neuroscience to understand symptoms in anxiety, depression and psychosis

Funder: Wellcome

Open

Closes:  23 July 2024

Sector: Healthcare

Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are, what your team does and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know.

If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers and how you stand out from the crowd. Add a photo, gallery or video for even more engagement.

Multi-million pound funding available from Wellcome to explore how neuroscience can contribute to our understanding of mental health symptoms. £2-£5 million per project team, duration of 3 to 5 years.

This award will fund innovative projects that combine computational and experimental neuroscience approaches to improve understanding of symptoms of anxiety, depression and psychosis.
Scope check deadline - 9 July.
More information
here.

Digital technology enabled interventions in Social Care

Funder: HTA/ NIHR

Opened: 22 March 2024

Closes: 1pm 24 July 2024

Sector: Social care

This Programme is accepting Stage 1 applications to their commissioned workstream for this research topic. Applications received by the advertised closing date will be considered at a first-stage funding committee meeting, and successful applicants will then be invited to submit a Stage 2 application. Applicants will have 8 weeks to complete and submit their Stage 2 application form.

This funding opportunity is eligible for a SWAT/SWAR (study within a trial or study within a review), which can help significantly improve methodology of future research as well as the host study.

Thee is a webinar to discuss the HTA Programme's current funding opportunities in social care on 21 May 2024, 12pm to 1.15pm. Applicants may register to attend just the webinar by emailing their name and institution to htaresearchers@nihr.ac.uk 

The HTA Programme is interested in proposals for the evaluation of a wide range of digital technologies for social care across both children and adult services, including, but not limited to:

  • digital applications for promoting behaviour change to prevent deterioration of a specific long-term condition or improve general wellbeing

  • technologies designed to improve the personal safety and/or well-being of people who draw on care and support services and carers, e.g. technologies aimed at preventing falls or alerting carers to a fall, geographical positioning systems (GPS), home monitoring systems

  • digital memory aids, e.g. technologies to support the following advice or guidance from health and social care practitioners and/or organising social care related aspects of their lives

  • digital interventions for loneliness or social isolation

  • remote assessments (or other care planning processes) (child development, occupational, etc.)

  • enablers of the adoption of digital technologies by citizens and their support networks, such as tools aimed at improving digital literacy and preventing digital exclusion among specific populations

  • robotics for assisting simple tasks such as cognitive assistive robots, socially assistive robots

Digital technologies include a broad range of both hardware and electronic devices, such as smart watches; software, such as mobile applications, and internet delivered services such as online support groups

 

Applicants should clearly define and justify the specific population of interest, study design and outcome measures. In defining these, they should ensure a strong emphasis on social care outcomes, as well as appropriate balance between considerations primarily affecting the users of assistive technologies (including people with lived experience and their support networks) such as ease of use, psychosocial wellbeing or requirements around privacy, and the implementation and economic factors of concern to local authorities and other social care organisations.

Other commissioning information.

Innovate UK Smart grants

Funder: Innovate UK

Opened: 25 April 2024

Closes: 11am 24 July 2024 

Sector: All

UK registered organisations can apply for a share of up to £25 million for game-changing and commercially viable R&D innovations that can significantly impact the UK economy. Applications can come from any area of technology and be applied to any part of the economy.
 

Projects of 6 to 18 months must have total eligible project costs between £100,000 and £500,000 and can be single or collaborative.   Projects of 19 to 24 months must have total eligible project costs between £100,000 and £1 million and be collaborative.   
Eligibility criteria.

Accelerated Knowledge Transfer 3

Funder: Innovate UK

Opened: 20 June 2024

Closes: 11am 31 July 2024

Sector: ALL

UK registered academic institutions, RTOs or Catapults can apply for a share of up to £1 million to fund innovation projects with businesses and not for profit organisations.

Projects must be led by a UK registered HE, FE, RTO or Catapult collaborating with UK registered businesses and not for profit organisations with four or more full time equivalent employees.

 

Projects must deliver targeted interventions to accelerate the evaluation or development of an innovation project or concept.

 

Business must contribute a minimum of 10% of total project costs.
More information here.

ABOVE (Arise Beyond Open Innovation for Value and Entrepreneurship)

Funders: Medilink Midlands, Anglia Ruskin University, and Essex County Council

Open

Closes: Ongoing until August 2024 (rolling applications)

Sector: Healthcare in Essex, UK

‘Arise Beyond Open Innovation for Value and Entrepreneurship’ (ABOVE) is a new collaborative programme delivered in partnership with Arise Innovation Hubs, part of Anglia Ruskin University. The ABOVE programme will provide innovation support grants as well as sector-specific events around the themes of health, performance and wellbeing. As a specialist provider of support to the life science sector,

Medilink Midlands continue to partner with Arise Innovation Hubs to provide expert guidance to SMEs on how to overcome barriers to growth throughout their innovation journey. Essex County Council has provided the funding for this project in support of their ten-year strategy to grow the life science, DigiTech, advanced manufacturing and engineering sectors, leading to more opportunity, jobs and growth across Essex.
 

Alongside an ongoing support and events programme, the ABOVE programme will provide a limited number of innovation grants. Essex SME’s can apply for up to £5,000 to help unlock their business potential.
More information

Efficacy studies seeking to improve the health and wellbeing of women (24/50)

Funder: NIHR/ MRC

Opened: 21 May 2024

Closes: 1pm 20 August 2024

Sector: Health& Life sciences

The MRC-NIHR Efficacy and Mechanism Evaluation (EME) Programme is inviting applications for efficacy trials that aim to improve the health and wellbeing of women. This could include, but is not limited to, trials investigating conditions that only affect women, or conditions that affect both men and women but may affect women either disproportionately or in a different way. It does not include maternity disparities - see NIHR Challenge – Maternity Inequalities.

There is no set upper limit for the duration or cost of applications, however value for money will be a key consideration.

All proposals submitted must describe an evaluation of an intervention or technology, which falls within the scope of the EME Programme. Applications are expected to detail the clinical need, scientific rationale and proof of concept for the intervention, as well as how the study has the potential to improve women's health. Applicants are encouraged to consider opportunities to embed the testing of mechanistic hypotheses within the main study, where
relevant.

Applications are particularly encouraged in the following areas:

  • Areas of research within which women have been historically under-represented.

  • Topics that are under-represented in the EME and HTA portfolios. Applicants can undertake searches of the funded portfolio on the NIHR Funding and Awards website.

  • Hypothesis-testing mechanistic studies to examine a differential response to a treatment between men and women (“mechanism of action” research). This may be embedded within an efficacy study, or make use of patients or samples from an existing NIHR study or other completed study, with the same eligibility criteria as a mechanistic study application to the current EME Researcher-Led funding opportunity.

  • Rare diseases that affect women.
     

More information

Clinical Study Grants

Funder: British Heart Foundation

Open

Closes: 5pm 29 August 2024

Sector: Healthcare

The Clinical Study Grant supports funding for over £350,000 for:

  • Interventional clinical trials: trials of specific interventions or pathways of care for the prevention, diagnosis and treatment of cardiovascular disease. Interventions include drugs, surgery, devices, psychological, physical and educational interventions.

  • Observational studies of specific patient groups that are hypothesis led and address a defined clinical question(s) over a fixed timescale (up to 5 years). The population of interest should be a patient population, who will usually be recruited within the NHS. The study should have a predefined outcome(s) that will lead to changes in clinical management directly or will inform the development of a clinical trial to test an intervention.

  • Clinical studies can include a mechanistic evaluation, either as a sub-study within a clinical trial or as part of an observational study.

More information.​

BridgeAI Supply Chain Demonstrator

Funder: Innovate UK

Opened: 24 June 2024

Closes: 11am 21 August 2024

Sectors: Logistics & transport, agriculture & food processing, construction

Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are, what your team does and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know.

If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers and how you stand out from the crowd. Add a photo, gallery or video for even more engagement.

These projects will be to accelerate the development and adoption of artificial intelligence solutions across supply chains of the UK economy. The projects are intended to benefit efficiency in supply chains and improve business decisions at firm level. Your project’s total grant funding request must be between £1.9 million and £2 million.
 

The aim of this competition is to develop a product or process that enables data from micro, small and medium sized enterprises (SMEs) and large organisations to be shared in a trust less environment. The product or process must enable the development of new Artificial Intelligence solutions for the benefit of supply chain efficiency and firm level productivity. The output of these projects must be in the form of a demonstrator.
 

 

Your project must demonstrate clear monetisation strategies that incentivize data sharing and business models that span benefits across organisations and sectors.
More information.

Competition 25 - Women's health

Funder: SBRI

Opened: 17 July 2024

Closes: 1pm 28 August 2024 

Sector: Healthcare & Life Sciences

Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are, what your team does and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know.

If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers and how you stand out from the crowd. Add a photo, gallery or video for even more engagement.

Under the overall theme of “Women’s Health”, this competition  invites early-stage innovations in the following three priority areas:

  • Gynaecological Conditions and Hormonal Health

  • Mental Health

  • Chronic Conditions and Long-term Health.

The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.

Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and last for six months. If successful, Phase 1 projects are entitled to apply for Phase 2 contracts for prototype development and early clinical evidence which are usually worth up to £800,000 (NET) over 12 months, subject to budget availability.

More information here.

Competition 25 - AMR

Funder: SBRI

Opened: 17 July 2024

Closes: 1pm 28 August 2024

Sector: Healthcare & Life Sciences

Under the overall theme of “Antimicrobial resistance (AMR)”, This competition  invites early-stage innovations in the following four priority areas:

  1. Point of care diagnostics, monitoring, and susceptibility testing

  2. Prescribing decision support and risk stratification

  3. Novel care delivery methods

  4. Infection prevention and control (IPC).

The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.

Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and last for six months. If successful, Phase 1 projects are entitled to apply for Phase 2 contracts for prototype development and early clinical evidence which are usually worth up to £800,000 (NET) over 12 months, subject to budget availability.

More information here.

Eurostars Funding

Funder: Horizon - European Union

Open: 

Closes: 12 September 2024

Sector: All

Innovative SMEs in any of the 37 participating countries can bid for up to €360,000 per project. Approximately 29% of all bids are likely to be successful. Innovate UK covers up to 60% of project costs in grants for SMEs. Innovate UK will not fund large companies, universities or research organisations as part of this grant. 

To apply, you must fulfill seven eligibility criteria:

  • The project consortium is led by an innovative SME from a Eurostars country.

  • The project consortium is composed of at least two entities that are independent from one another.

  • The project consortium is composed of entities from at least two participating countries with a minimum of one organisation from an EU or Horizon Europe Associated Country.

  • The budget of the SMEs from the participating countries (excluding any subcontracting) is 50% or more of the total project cost.

  • No single participant or country is responsible for more than 70% of the budget of the project.

  • The project duration is 36 months or less.

  • The project has an exclusive focus on civil applications.

 

Innovate UK has additional national criteria for projects to be eligible to receive funding - see here for details.

Applications can be made here.

Competition 26 - Stroke

Funder: SBRI

Opened: 5 July 2024

Closes: 18 September 2024

Sector: Healthcare

Under this Phase 3 Funding Competition, three challenges have been identified via consultation with clinicians and other stakeholders working in provision of care across the spectrum and review of the James Lind Alliance Stroke Priority Setting Partnership for Stroke Research:

  • Early diagnosis

  • Rehabilitation

  • Life after stroke.

Emphasis should be placed on how the technology/innovation will address any challenges associated with health inequalities, such as demographic and geographic disparities, and it is expected that applicants provide details on how they will address these e.g. provide details on the care pathway the intervention will affect and how it can improve this.

The aim of the competition is to facilitate the collection of evidence in real-world settings and build on the value proposition required by commissioners and regulators to accelerate the uptake of the innovation into relevant health or social care settings.

The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.
 

Maximum grant is £500,000 excl VAT.
More information here.

Register for the launch webinar, Tues 23 July, 1-3pm. Sign up on Eventbrite

Accessible and Affordable Tests for Early Detection of Heritable Cancers in European Regions

Funder: European Commission

Opened: 18 April 2024

Closes: 18 September 2024

Sector: Healthcare

A single stage funding call, part of the Horizon Europe programme. 

Expected EU Contribution per Project -between €10 million and €12 million out of a total indicative budget of €35 million.

Proposals should aim to deliver results through validating, piloting, and upscaling genetic, multi-omics, or other biomarker-based tests for early detection of cancers with underlying heritable genetic risk in routine healthcare. There are six topics included in the call:

  • Improve understanding of the development of cancer in the context of the environment, work, and lifestyle in the broadest possible sense,

  • Enhance cross-policy cancer prevention strategies,

  • Optimise the diagnostics and treatment of cancer based on the principle of equitable access,

  • Improve the quality of life of cancer patients, survivors and their families through widely analysing all key factors and needs that are related to the quality of life,

  • Accelerate the digital transformation of research, innovation and health systems.

The work to be funded will include:

  • Conducting clinical and socio-economic feasibility studies.

  • Co-creating testing protocols and procedures with end-users, including healthcare professionals and citizens.

  • Extensively piloting and upscaling testing in at least 3 different EU Member States or Associated Countries, with a focus on Eastern Europe.

  • Collaborate with EIT-Health KIC networks for support in entrepreneurship, education, and innovation.

More information

Knowledge transfer partnerships: 2024 to 2025 Round 3

Funder: Innovate UK

Opened: 1 July 2024 

Closes: 11am 25 September 2024 

Sector: Healthcare & Life Sciences

Led by an UK higher education (HE) or further education (FE) institution, research and technology organisation (RTO) or Catapult., your application must be for a specific, strategic innovation project that tackles one or more challenges faced by the business partner.

It can be any kind of project and must show:

  • why the business needs this Knowledge Transfer Partnership (KTP)

  • what new knowledge is required by the business

  • what new capabilities will be embedded as a result of the KTP.

Typically, a project’s total costs are £8,500 per month. Projects must be between 12 and 36 months. A proportion of the knowledge base partners’ costs will be funded by Innovate UK. The remainder of the project costs are paid by the business partner.

More information here.

Novel and Emerging Technologies (NET) Grants

Funder: Heart Research UK

Open

Closes: 2 October 2024

Sector: Healthcare

This unique grant  (limit of £300,000) gives researchers the opportunity to apply for funding to develop a novel and emerging technology or a new application of an existing technology.

NET grants are research projects which focus on the development of new and innovative technologies to diagnose, treat and prevent heart disease and related conditions.

Research projects with the emphasis on (1) novel and emerging technologies and (2) their application into cardiovascular disease prevention and/or treatment, which can be expected to benefit patients within a foreseeable timeframe, will be considered.

Appropriate approaches include tissue and bioengineering, the development and evaluation of new diagnostic devices, bio imaging, nanotechnology, biomaterials, genomic, and proteomic approaches, computational biology and bioinformatics.

Funding clinical trials through the NET Grant scheme is not appropriate. However, research projects incorporating a small scale clinical study to demonstrate the feasibility of the technology will be considered, providing that the clinical study is not the main focus of the research programme. Projects that are more specifically clinically focused should be directed to the Translational Research Project (TRP) grants scheme.

For example, the grant may support emerging strategies/ technologies in the management of risk factors, the evaluation of invasive cardiology procedures (eg angioplasty and stent replacement), and evaluation of new surgical approaches to cardiovascular disease, strategies aimed at improving the efficacy of ventricle assist and other devices, and the outcomes of resuscitation after cardiac arrest.

A multidisciplinary approach is encouraged. Proposals should be based on excellent science and also clearly describe the future clinical implications and the translational strategy.

More information.

EIC Accelerator

Funder: Horizon Europe

Opens: 14 March 2024

Closes: 3 October 2024

Sector: All technology sectors

The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs that:

  • have a innovative, game changing product, service or business model that could create new markets or disrupt existing ones in Europe and even worldwide,

  • have the ambition and commitment to scale up,

  • are looking for substantial funding, but the risks involved are too high for private investors alone to invest

Applications consist of:

  • A 5-page form where you must summarise your proposal and respond to a set of questions on your innovation, your potential market and your team;

  • A pitch-deck of up to ten slides in pdf format;

  • A video pitch of up to three minutes where the core members of your team (up to three people) should provide the motivation for your proposal.

Applicants will normally receive feedback within 4 weeks.

More information.

Call for Proposals to increase Health Literacy for Cancer Prevention and Care

Funder: European Commission 

Opened: 18 June 2024

Closes: 10 October 2024 

Sector: Healthcare

The European Commission (EC) has announced a call for proposals to support health literacy for cancer prevention and care, to improve health literacy and to focus on reducing inequalities in cancer prevention and care.

Indicative funding of 1 million Euros per project with a duration of 3 years.

The results of the project should include:

  • guidelines, recommendations, lessons learned, best practices on how to increase health literacy in cancer prevention and care

  • information materials (e.g. manuals for patients, leaflets, websites, videos) to citizens/patients of all ages (focusing on vulnerable populations) and healthcare specialists;

  • mapping of sources providing reliable, accurate information on the internet, in easy-to understand language;

  • training course for healthcare specialists.

More information here and here.

Canada-UK: Biomanufacturing of Biologics and Advanced Therapies Round 2

Funders: Innovate UK, National Research Council of Canada Industrial Research Assistance Program

Opened: 8 May 2024

Closes: 11am 16 October 2024

Sector: Healthcare & Life sciences

UK registered organisations can apply for a share of up to £3 million for collaboration with Canadian SMEs on joint R&D projects, for enabling technologies and innovations in biomanufacturing of biologics and advanced therapies.

 

The aim of this competition is to stimulate the development and implementation of innovative technologies in biomanufacturing. The objective is to build the desired flexibility and technical capabilities required for the development and economically sustainable production of the next generation vaccines and therapies.

The total grant funding request for all UK partners can be up to £600,000 for each application. The total funding request for all Canadian partners combined can be up to CA$1 million for each application.

More information.

Advancing Healthcare Small Grants

Funder: Barts Charity

Open

Closes: 17 October 2024

Advancing Healthcare Small Grants provide funding of up to £50,000 for NHS staff to pilot new ideas, technologies and ways of working within Barts Health NHS Trust that could advance healthcare delivery and improve the health of its local community. At least one applicant must be employed by Barts for the duration of the proposed work. This grant can be applied for 4 times a year. Duration of funding - 18 months.

More information.

Sector: Healthcare

Clinical Study Grants

Funder: British Heart Foundation

Open

Closes: 5pm 23 October 2024

Sector: Healthcare

The Clinical Study Grant supports funding for over £350,000 for:

  • Interventional clinical trials: trials of specific interventions or pathways of care for the prevention, diagnosis and treatment of cardiovascular disease. Interventions include drugs, surgery, devices, psychological, physical and educational interventions.

  • Observational studies of specific patient groups that are hypothesis led and address a defined clinical question(s) over a fixed timescale (up to 5 years). The population of interest should be a patient population, who will usually be recruited within the NHS. The study should have a predefined outcome(s) that will lead to changes in clinical management directly or will inform the development of a clinical trial to test an intervention.

  • Clinical studies can include a mechanistic evaluation, either as a sub-study within a clinical trial or as part of an observational study.

More information.​

Technology-Enabled Social Care Highlight Notice

Funder: NIHR

Opened: 10 July 2024

Closes: 30 October 2024

Sector: Social Care

​This is a two stage process. The amount awarded and the length of the funding period depends on the nature of the proposed work. 

The NIHR Research Programme for Social Care (RPSC) is inviting proposals for collaborative research projects that examine the development and utilisation of digital technology in social care. This includes artificial intelligence (AI) or digital devices in the provision of social care and/or to support any aspect of the lives of adults or children with social care needs in the UK.

Where possible applications should demonstrate how they are in alignment with one or more of the objectives set out in People at the Heart of Care and one or more of the identified priorities for innovation and scaling within them:

  • Objective 1 People have choice, control and support to live independent lives

  • Objective 2. People can access outstanding quality and tailored care and support

  • Objective 3. People find adult social care fair and accessible.

In children’s social care, research must be in line with the principles of the Children's Social Care National Framework (.PDF). Applications will need to demonstrate how any technology-enabled social care interventions will increase the effectiveness of social care services, provide value for money, and benefit young people using children's social care services and/or carers.

More information here.

A virtual Q&A webinar for this call will take place on Tuesday 23 July from 10am to 11am for potential applicants. A recording and a copy of the slides will be made available upon request after the webinar, by contacting the RPSC team at rpsc@nihr.ac.ukRegister for the webinar via eventbrite.

SMART: SCOTLAND

Funder: Scottish Enterprise

Opens: 09 November 2023

Closes: 09 November 2024

Sector: All

SMART:SCOTLAND is a research and development (R&D) grant for small and medium-sized businesses that aims to support high risk, highly ambitious projects. It covers conducting feasibility studies to show how ideas could work in the real world and supports activities that have a commercial endpoint. The grant is only available to small and medium enterprises (SMEs) based in Scotland and supports the activities of commercially focused R&D projects.

The grant can support up to 70% of the eligible costs for a small enterprise and up to 60% of the eligible costs for a medium enterprise. Studies must last between 6 and 18 months, and the maximum grant is £100,000.

More information.

Smart Flexible Innovation Support (FIS)

Funder: The Welsh Government

Opens: 15 June 2023

Closes: 09 November 2024

Sector: All

The Welsh Government is investing £30 million in new programmes that will help Welsh organisations develop and embed new innovative products and services to help improve people’s lives, grow the economy and address the climate and nature emergency.

SMART FIS is not restricted to businesses and research organisations.  It is open to any organisation wishing to engage in research, development and innovation (RD&I), including the third sector, local authorities and health boards.

For a new organisation this might mean accessing technology to get a new idea off the ground; for a developing one, it could be help with a project which you know has potential; and for an established organisation it might be about specialist know-how to give you an international edge by opening up new markets.

Funding is dependent on the organisation and type of project. A typical example would be £100,000 per year for 2 years.

More information.

Implementation research for management of multiple long-term conditions in the context of non-communicable diseases

Funder: European Commission

Opened: 25 April 2024 

Closes: 5pm (CET) 26 November 2024

Sector: Healthcare

It is expected that 5 grants will be awarded of €3m - €4m each.

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to some of the following expected outcomes:

  • Health care practitioners and providers in low- and middle-income countries (LMICs) and/or those in high-income countries (HICs) serving disadvantaged populations have access to and use specific guidelines to implement health interventions that improve the availability of effective, equitable, efficient, integrated, patient-centred, safe, and timely care and the overall quality of life for people living with multiple long-term conditions including non-communicable diseases (NCDs).

  • Public health managers and authorities, including from other relevant sector (e. g., social, culture) have access to improved insights and evidence on how to decrease the fragmentation of care for patients living with multiple chronic conditions, and ensure continuity of care across all stages of disease progression. They use this knowledge to design policies to reduce health inequities.

  • Adopting an implementation science approach to studying interventions for management of multiple long-term conditions in the context of NCDs, researchers, clinicians and authorities have an improved understanding how the proposed interventions could be adopted in LMICs and/or disadvantaged populations of HICs setting, taking into account specific social, political, economic and cultural contexts.

  • Communities and local stakeholders and authorities are fully engaged in implementing and taking up interventions for management of multiple long-term conditions in the context of NCDs and thus contribute to deliver better health.
     

The following types of projects will NOT be funded:
i) proposals focused on primary prevention of NCDs or other chronic conditions;
ii) proposals with the primary aim of informing the development and/or selection of an intervention for a given context, where the implementation component will be explored in a future project;
iii) epidemiological cohorts;
iv) etiological work, mechanistic, or epidemiological research, unless an essential component of a focused study to develop implementation research approaches;
v) clinical trials, validation studies, or intervention efficacy studies for a new or established pharmacological agent or behavioural intervention.

More information.

Artificial intelligence, engineering biology and quantum technologies

Funder: MRC

Opened: 1 April 2024

Closes: 4pm 31 March 2025

Sector: Healthcare and Life sciences

During the highlight period MRC particularly welcomes applications from teams that are applying AI, engineering biology or quantum technologies, to better enable them to meet relevant MRC board and panel and cross-cutting themes. MRC will usually fund up to 80% of your project’s full economic cost.

Artificial intelligence (AI) : You should be clear on the biomedical research challenge to be addressed, how use of AI will deliver impact beyond incremental optimisation of current systems, and where, if applicable complementarity exists with UKRI strategies (for example Transforming our World with AI) and existing investments in the same area (for example Responsible AI UK).
More information
here.

Tackling obesity

Funder: MRC

Open

Closes: No closing date

Sector: Healthcare & Life sciences

Apply for funding to develop effective strategies to tackle overweight and obesity.

‘Tackling obesity’ is open to applications submitted to the Population and Systems Medicine Board.

The MRC is seeking multidisciplinary and interdisciplinary applications to tackle overweight and obesity. The research should support evidence-based approaches to improve health in real-life settings. In particular, the MRC wishes to better understand what makes an effective intervention. This is by encouraging greater integration and synergy across existing pockets of expertise in the biological, behavioural, psychological, environmental and social sciences.

You should apply through the existing funding opportunity most relevant to your science area and career stage. There is no limit to the funding you can apply for, but it should be appropriate to the research project. We will usually fund up to 80% of your project’s full economic cost. This is an ongoing funding priority for the Population and Systems Medicine Board. Application rounds close every January, May and September.

More information.

Global Innovation Fund- Grants

Funder: Global Innovation Fund

Open, no closing date

Sector: All

The Global Innovation Fund is a non-profit, impact-first investment fund headquartered in London with offices in Washington, D.C. and Nairobi. It invests in the development, rigorous testing, and scaling up of new products, services, business process, or policy reforms that are more cost-effective than current practice and targeted at improving the lives of the world's poorest people.

It accepts applications from organisations working in any sector in any developing country. Any type of organisation may apply. This includes social enterprises, for-profit companies, non-profit organisations, government agencies, international organisations, and research institutions in any country. It is recommended that individual innovators, entrepreneurs, or researchers apply through an affiliated organisation. 

More information.

Catapult/RTO Grants

Funder: Innovate UK Business Growth

Open, no closing date

Sector: All

Up to £15,000 grants available for:

  • Sector specific advice on expertise;

  • Testing and/or development work;

  • Market analysis, cost modelling etc;

  • Identifying opportunities for R&D, partnership building & collaboration, and more.

More information.​

Past Funding Calls
UK-Taiwan CRD 2024

Funder: Innovate UK

Opened: 08 April 2024

Closed: 17 July 2024

Sectors: Biotech, Green energy, AI, smart manufacturing

The aim of this competition is to fund business led, collaborative research and development (CR&D) projects focused on industrial research, for innovative proposals developed between the UK and Taiwan. 

UK registered businesses can apply for a share of up to £5 million (maximum £900,000 each) for the purpose of developing innovative proposals with Taiwan. You must collaborate with at least one Taiwan business applying under the equivalent DoIT programme.

The projects Innovate UK fund are expected to result in a new product, industrial process or service, be innovative, involve a technological risk, and have high market potential.

It would particularly welcome applications from the following sectors:

 

  • smart technology, for example next generation communication, semiconductor technology and space technology

  • green energy technologies, for example electric vehicles, hydrogen transportation, renewable energy, future grids and carbon capture utilisation and storage

  • smart manufacturing

  • biotechnology, for example medical materials and devices

  • service innovation, for example the Internet of Things, Big Data, Artificial Intelligence, 5G and 6G

More information.

Funder: MRC

Opened: 5 June 2024

Closed: 4pm 17 July 2024